InvestorsHub Logo
Followers 29
Posts 2180
Boards Moderated 0
Alias Born 12/13/2016

Re: Jonjones325 post# 458053

Wednesday, 05/01/2024 6:37:32 PM

Wednesday, May 01, 2024 6:37:32 PM

Post# of 460118
Jon....you are on the right track with the discussion of a "partnership" at least for Alzheimer's. That has been voiced strongly by Missling in the past. I think it was approached with Biogen over 2-73's early indication for MS, but the competition of 2-73 and aducanumab in Alzheimer's destroyed the two company's cooperation at the time (MS is still on the board for 2-73). I would venture that an MMA will be followed or proceeded by a partnership with someone like Merck. Merck's success with Keytruda, now being used in 16 cancer applications, would give it impetus to partner with a company who has two drugs that have multiple applications in neuroscience!
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News